Oxitec appoints Hadyn Parry as CEO, effective from 3rd November 2008.

Monday, October 13th 2008

Company Moves Towards Commercial Phase, Targeting Asian and American Markets

Oxitec Ltd, a company dedicated to combating global diseases spread by insects, such as dengue fever and malaria, announced today that it has appointed Hadyn Parry as CEO, effective from 3rd November 2008.
Mr Parry has an extensive background in the Life Science sector. During his fifteen [...]